CV Technologies Inc.: World Science Body Selects COLD-fX’R’ Clinical Trial Results For Inclusion In Major Medical Publication

CV Technologies Inc. (TSX:CVQ), maker of COLD-fX®, today provided an update to the business, scientific and investment community.